Patents by Inventor Christopher B. Eiben

Christopher B. Eiben has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for converting methanol into hydrogen peroxide and carbon dioxide
    Publication number: 20240093245
    Abstract: The present invention provides for a method for producing hydrogen peroxide comprising: (a) contacting a methanol with a methanol oxidase bound with a flavin adenine dinucleotide (FAD) cofactor, such that the methanol is oxidized into a formaldehyde and the FAD cofactor is reduced into FADH2; (b) contacting the formaldehyde with the methanol oxidase or a formate oxidase bound with a FAD cofactor, such that the formaldehyde is oxidized into a formate and the FAD is reduced into FADH2; and (c) contacting oxygen with one or more of the FADH2 to produce hydrogen peroxide and oxidize FADH2 into FAD. The present invention also provides for a fusion protein comprising any two or all of methanol oxidase, formate oxidase, and formaldehyde dismutase.
    Type: Application
    Filed: April 11, 2022
    Publication date: March 21, 2024
    Applicant: The Regents of the University of California
    Inventors: Christopher B. Eiben, Jay D. Keasling
  • Heterologous pathway to produce terpenes
    Patent number: 10167488
    Abstract: Cells comprising a heterologous metabolic pathway are configured to produce a terpene product containing non-multiples of five carbon, particularly wherein the pathway comprises heterologous Lepidoptera insect juvenile hormone biosynthetic pathway enzymes of the insect's mevalonate pathway.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: January 1, 2019
    Assignee: The Regents of the University of California
    Inventors: Jay D. Keasling, Christopher B. Eiben
  • Heterologous Pathway to Produce Terpenes
    Publication number: 20180119176
    Abstract: Cells comprising a heterologous metabolic pathway are configured to produce a terpene product containing non-multiples of five carbon, particularly wherein the pathway comprises heterologous Lepidoptera insect juvenile hormone biosynthetic pathway enzymes of the insect's mevalonate pathway.
    Type: Application
    Filed: November 3, 2017
    Publication date: May 3, 2018
    Applicant: The Regents of the University of California
    Inventors: Jay D. Keasling, Christopher B. Eiben